New York Life Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Sell |
|
|||||
|
2025
Q1 | $1.83M | Buy |
|
|||||
|
2024
Q4 | $2.24M | Sell |
|
|||||
|
2024
Q3 | $2.57M | Sell |
|
|||||
|
2024
Q2 | $2.8M | Buy |
|
|||||
|
2024
Q1 | $3.31M | Buy |
|
|||||
|
2023
Q4 | $1.69M | Sell |
|
|||||
|
2023
Q3 | $2.49M | Buy |
|
|||||
|
2023
Q2 | $2.06M | Buy |
|
|||||
|
2023
Q1 | $1.46M | Buy |
|
|||||
|
2022
Q4 | $1.57M | Buy |
|
|||||
|
2022
Q3 | $1.41M | Buy |
|
|||||
|
2022
Q2 | $1.53M | Buy |
|